151
|
Kang JH, Choi HJ, Cho HY, Lee JH, Ha IS, Cheong HI, Choi Y. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis associated with CLDN16 mutations. Pediatr Nephrol 2005; 20:1490-3. [PMID: 16047219 DOI: 10.1007/s00467-005-1969-7] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2005] [Revised: 03/23/2005] [Accepted: 03/23/2005] [Indexed: 10/25/2022]
Abstract
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC), an autosomal recessive renal tubular disorder, is characterized by the impaired tubular reabsorption of magnesium and calcium in the thick ascending limb of the loop of Henle and an eventual progression to end-stage renal disease. Recent studies have reported that this disease is caused by mutations in the CLDN16 gene, which encodes the tight junction protein, paracellin-1. Paracellin-1 belongs to the claudin family and regulates the paracellular transport of magnesium and calcium. Here, we report on two Korean siblings with typical clinical features of FHHNC in association with compound heterozygous mutations, G233C and 800delG, in CLDN16. Their parents were asymptomatic heterozygous carriers of the single mutations. This is the first report of FHHNC in Korea, and the mutations reported are novel.
Collapse
Affiliation(s)
- Ju Hyung Kang
- Department of Pediatrics, Seoul National University Children's Hospital, 28 Yongon-Dong, Chongro-Gu, 110-744 Seoul , Korea
| | | | | | | | | | | | | |
Collapse
|
152
|
Tasic V, Dervisov D, Koceva S, Weber S, Konrad M. Hypomagnesemia with hypercalciuria and nephrocalcinosis: case report and a family study. Pediatr Nephrol 2005; 20:1003-6. [PMID: 15856319 DOI: 10.1007/s00467-005-1853-5] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2004] [Revised: 12/16/2004] [Accepted: 01/18/2005] [Indexed: 10/25/2022]
Abstract
A 7-month-old male infant was referred for investigation after a documented febrile urinary tract infection. His past medical history was characterized by episodes of unexplained fever and mild dehydration. The ultrasound examination of his kidneys demonstrated bilateral diffuse medullary nephrocalcinosis. His serum and urine biochemistry revealed hypomagnesemia (0.4 mmol/l), hyperuricaemia (506 micromol/l), mildly increased iPTH (71 pg/ml) and hypercalciuria (16.0 mg/kg/day). The diagnosis of familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) was confirmed by mutational analysis of the CLDN16 gene, encoding paracellin-1. Sequencing displayed a homozygous Leu151Phe exchange affecting the first extracellular loop of paracellin-1. There were eight family relatives who underwent biochemical analysis, renal ultrasound and genetic investigation for CLDN16 mutations. Five of them were found to be heterozygous for the Leu151Phe mutation. Two heterozygotes (the mother and the maternal grandfather) presented with hypercalciuria. The grandfather had a history of recurrent passage of calculi. These findings point to the role of heterozygous CLDN16 gene mutations in renal pathophysiology. In conclusion, patients suspected of having FHHNC should be screened for CLDN16 mutations, especially with respect to genetic counseling. In addition, heterozygotes at risk should be clinically assessed in order to prevent renal complications of hypercalciuria.
Collapse
Affiliation(s)
- Velibor Tasic
- University Children's Hospital, 17 Vodnjanska, 1000 Skopje, Macedonia.
| | | | | | | | | |
Collapse
|
153
|
Chubanov V, Gudermann T, Schlingmann KP. Essential role for TRPM6 in epithelial magnesium transport and body magnesium homeostasis. Pflugers Arch 2005; 451:228-34. [PMID: 16075242 DOI: 10.1007/s00424-005-1470-y] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2005] [Accepted: 05/12/2005] [Indexed: 12/22/2022]
Abstract
Magnesium is an important cofactor for many biological processes such as protein synthesis, nucleic acid stability and neuromuscular excitability. The extracellular magnesium concentration is regulated tightly by the extent of intestinal absorption and renal excretion. Despite their critical role in magnesium handling, the molecular mechanisms mediating transepithelial transport are still not understood completely. Recently, genetic studies in patients with primary hypomagnesaemia and secondary hypocalcaemia (HSH), a combined defect of intestinal magnesium absorption and renal magnesium conservation, have identified "transient receptor potential (melastatin) 6" (TRPM6) as the first component involved directly in epithelial magnesium reabsorption. TRPM7, the closest homologue of TRPM6, has a central role in Mg(2+) uptake in vertebrate cells since TRPM7-deficient cells become Mg(2+) deficient and are not viable. TRPM7 has been characterized functionally as a constitutively active ion channel permeable for a variety of cations including calcium and magnesium and regulated by intracellular concentrations of magnesium and/or magnesium-nucleotide complexes. Both proteins share the unique feature of cation channels fused to serine/threonine kinase domains. This review summarizes recent data that has emerged from molecular genetic, biochemical and electrophysiological studies on these fascinating two new proteins and their involvement in epithelial magnesium transport.
Collapse
Affiliation(s)
- Vladimir Chubanov
- Institute of Pharmacology and Toxicology, Philipps-University, Marburg, Germany
| | | | | |
Collapse
|
154
|
Gambaro G, Vezzoli G, Casari G, Rampoldi L, D'Angelo A, Borghi L. Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis 2005; 44:963-86. [PMID: 15558518 DOI: 10.1053/j.ajkd.2004.06.030] [Citation(s) in RCA: 88] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Idiopathic calcium nephrolithiasis is a multifactorial disease with a pathogenesis that involves a complex interaction of environmental and individual factors. This review discusses what is known about monogenic renal calcium stone-related disorders, provides an update on genetic research in calcium nephrolithiasis and such intermediate phenotypes as idiopathic hypercalciuria, discusses the problems that these conditions pose to clinicians and geneticists interested in their pathogenesis, and proposes some method tools potentially useful in this research frame of reference.
Collapse
Affiliation(s)
- Giovanni Gambaro
- Department of Biomedical and Surgical Sciences, Division of Nephrology, University of Verona, Verona, Italy.
| | | | | | | | | | | |
Collapse
|
155
|
Abstract
Hereditary disorders of magnesium homeostasis comprise a heterogenous group of diseases mainly affecting the renal conservation of magnesium. In the past few years, genetic studies in affected individuals disclosed the first molecular components of epithelial magnesium transport: the tight junction protein paracellin-1 (claudin-16) was discovered as a key player in paracellular magnesium and calcium reabsorption in the thick ascending limb of Henle's loop and the gamma-subunit was identified as a component of renal Na+ -K+ -ATPase critical for transcellular magnesium reabsorption in the distal convoluted tubule. However, the molecular identity of proteins directly involved in cellular magnesium transport remained largely unknown until a series of recent studies highlighted the critical role of two members of the transient receptor potential (TRP) family, for body magnesium homeostasis. TRPM6 and TRPM7 belong to the melastatin-related TRPM subfamily of TRP channels whose eight members exhibit a significant diversity in domain structure as well as cation selectivity and activation mechanisms. Both proteins share the unique feature of an atypical kinase domain at their C-terminus for which they have been termed 'chanzymes' (channels plus enzymes). Whereas electrophysiological and biochemical analyses identified TRPM7 as an important player in cellular magnesium homeostasis, the critical role of TRPM6 for epithelial magnesium transport emerged from the discovery of loss-of-function mutations in patients with a severe form of hereditary hypomagnesaemia called primary hypomagnesaemia with secondary hypocalcaemia or HSH. The aim of this review is to summarize the data emerging from molecular genetic, biochemical and electrophysiological studies on these fascinating two new proteins combining ion channel and enzyme functions/properties.
Collapse
Affiliation(s)
- Karl P Schlingmann
- University Children's Hospital, Deutschhausstr. 12, 35037 Marburg, Germany.
| | | |
Collapse
|
156
|
Jeck N, Schlingmann KP, Reinalter SC, Kömhoff M, Peters M, Waldegger S, Seyberth HW. Salt handling in the distal nephron: lessons learned from inherited human disorders. Am J Physiol Regul Integr Comp Physiol 2005; 288:R782-95. [PMID: 15793031 DOI: 10.1152/ajpregu.00600.2004] [Citation(s) in RCA: 89] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The molecular basis of inherited salt-losing tubular disorders with secondary hypokalemia has become much clearer in the past two decades. Two distinct segments along the nephron turned out to be affected, the thick ascending limb of Henle's loop and the distal convoluted tubule, accounting for two major clinical phenotypes, hyperprostaglandin E syndrome and Bartter-Gitelman syndrome. To date, inactivating mutations have been detected in six different genes encoding for proteins involved in renal transepithelial salt transport. Careful examination of genetically defined patients (“human knockouts”) allowed us to determine the individual role of a specific protein and its contribution to the overall process of renal salt reabsorption. The recent generation of several genetically engineered mouse models that are deficient in orthologous genes further enabled us to compare the human phenotype with the animal models, revealing some unexpected interspecies differences. As the first line treatment in hyperprostaglandin E syndrome includes cyclooxygenase inhibitors, we propose some hypotheses about the mysterious role of PGE2in the etiology of renal salt-losing disorders.
Collapse
Affiliation(s)
- Nikola Jeck
- MD, Univ. Children's Hospital, Philipps-Univ., Deutschhausstrasse 12, D-35037 Marburg, Germany. )
| | | | | | | | | | | | | |
Collapse
|
157
|
Loris Pablo C, Martín de Vicente C, Abio Albero S, Justa Roldán M, Ferrer Novella C. [Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Association with ocular abnormalities]. An Pediatr (Barc) 2005; 61:502-8. [PMID: 15574250 DOI: 10.1016/s1695-4033(04)78436-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Abstract
BACKGROUND Familial hypomagnesemia with hypercalciuria and nephrocalcinosis is an unusual disease that usually leads to end-stage renal failure. There is no specific treatment and, to a variable degree, patients with this disease present ocular abnormalities. The illness is due to a defect in the reabsorption of magnesium and calcium at the thick ascending limb of Henle because of a mutation of the PCLN-1 gene, which encodes a protein, paracellin-1, which intervenes in the reabsorption of both cations. OBJECTIVE To review outcome and the incidence of ocular abnormalities in our patients and in cases described in Spain and to compare the incidence found with that in groups from other countries. METHOD Retrospective study of a group of patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis diagnosed at a hospital. RESULTS There were six girls and three boys with clinical symptoms of polyuria, polydipsia, and less frequently, urinary tract infections and lithiasis. All had hypomagnesemia, hypercalciuria and nephrocalcinosis. Five of the patients had renal failure at diagnosis and four underwent transplantation without recurrence. Eight patients had diverse ocular abnormalities. Eighty-one percent of Spanish patients had ocular abnormalities compared with 24 % of those from other countries. There was no evidence of successful medical treatment. CONCLUSIONS Almost half of the patients presented chronic renal failure at diagnosis and most of the patients reached end-stage renal failure in the second or third decade of life. Normal glomerular filtration rate was found only in patients diagnosed at an early age. The most frequent extra-renal association in Spanish patients (81 %) corresponded to ocular abnormalities. Effective treatment consists of kidney transplantation that completely corrects the tubular disorder.
Collapse
Affiliation(s)
- C Loris Pablo
- Unidad de Nefrología Pediátrica, Hospital Infantil Universitario Miguel Servet, Zaragoza, Spain.
| | | | | | | | | |
Collapse
|
158
|
Abstract
Hypercalciuria is an important, identifiable, and reversible risk factor in stone formation. The foremost and most fundamental step in dissecting the genetics of hypercalciuria is understanding its pathophysiology. Hypercalciuria is a complex trait. This article outlines the various factors that compromise the attempt to dissect the genetics of hypercalciuria, summarizes the clinical and experimental monogenic causes of hypercalciuria, and outlines the initial results from attempts in studying polygenic hypercalciuria. Finally, the problem is set in perspective of the current database, technologic advances and limitations are highlighted, and prospects of further advances in the field are speculated upon.
Collapse
Affiliation(s)
- Orson W Moe
- Charles and Jane Pak Center of Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8855, USA.
| | | |
Collapse
|
159
|
Abstract
The fundamental functions of epithelia and endothelia in multicellular organisms are to separate compositionally distinct compartments and regulate the exchange of small solutes and other substances between them. Tight junctions (TJs) between adjacent cells constitute the barrier to the passage of ions and molecules through the paracellular pathway and function as a 'fence' within the plasma membrane to create and maintain apical and basolateral membrane domains. How TJs achieve this is only beginning to be understood. Recently identified components of TJs include the claudins, a family of four-transmembrane-span proteins that are prime candidates for molecules that function in TJ permeability. Their identification and characterization have provided new insight into the diversity of different TJs and heterogeneity of barrier functions in different epithelia and endothelia.
Collapse
Affiliation(s)
- Kursad Turksen
- Ottawa Health Research Institute, Ontario K1Y 4E9, Canada.
| | | |
Collapse
|
160
|
Ikari A, Hirai N, Shiroma M, Harada H, Sakai H, Hayashi H, Suzuki Y, Degawa M, Takagi K. Association of Paracellin-1 with ZO-1 Augments the Reabsorption of Divalent Cations in Renal Epithelial Cells. J Biol Chem 2004; 279:54826-32. [PMID: 15496416 DOI: 10.1074/jbc.m406331200] [Citation(s) in RCA: 71] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Paracellin-1 (PCLN-1) belongs to the claudin family of tight junction proteins and possibly plays a critical role in the reabsorption of magnesium and calcium. So far, the physiological properties of PCLN-1 have not been clarified. In the present study, we investigated whether PCLN-1 is associated with ZO-1. We also investigated whether (45)Ca(2+) transport across the paracellular barrier is affected by this association. In vitro binding analysis using glutathione S-transferase fusion protein showed that the C-terminal TRV sequence, especially Thr and Val residues, of PCLN-1 interacts with ZO-1. Next, PCLN-1 was stably expressed in Madin-Darby canine kidney cells using a FLAG tagging vector. ZO-1 was co-immunoprecipitated with the wild-type PCLN-1 and the alanine substitution (TAV) mutant. However, mutants of the deletion (Delta TRV) and the alanine substitution (ARV and TRA) inhibited the association of PCLN-1 with ZO-1. Confocal immunofluorescence demonstrated that the wild-type PCLN-1 and the TAV mutant localized in the tight junction along with ZO-1, but the Delta TRV, ARV, and TRA mutants were widely distributed in the lateral membrane including the tight junction area. Interestingly, monolayers of cells expressing the wild-type PCLN-1 and the TAV mutant showed higher activities of (45)Ca(2+) transport from apical to basal compartments, compared with those expressing the Delta TRV, ARV, and TRA mutants and the mock cells. (45)Ca(2+) transport was inhibited by increased magnesium concentration suggesting that magnesium and calcium were competitively transported by PCLN-1. It was noted that a positive electrical potential gradient enhanced (45)Ca(2+) transport from apical to basal compartments without affecting the opposite direction of transport. Thus, PCLN-1 localizes to the tight junction followed by association with ZO-1, and the PCLN-1.ZO-1 complex may play an essential role in the reabsorption of divalent cations in renal epithelial cells.
Collapse
Affiliation(s)
- Akira Ikari
- Department of Environmental Biochemistry and Toxicology, University of Shizuoka, 52-1 Yada, Shizuoka 422-8526, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
161
|
Knohl SJ, Scheinman SJ. Inherited hypercalciuric syndromes: Dent's disease (CLC-5) and familial hypomagnesemia with hypercalciuria (paracellin-1). Semin Nephrol 2004; 24:55-60. [PMID: 14730510 DOI: 10.1053/j.semnephrol.2003.08.011] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Dent's disease and familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) are inherited diseases in which hypercalciuria, nephrocalcinosis, and renal failure are prominent features. Dent's disease resembles a Fanconi syndrome, with impaired reabsorption in the proximal tubule; FHHNC, with urinary loss of magnesium and calcium, is associated with impaired cation transport in the thick ascending limb of Henle's loop. Gene mapping in families and positional cloning led in both cases to identification of the responsible gene. Dent's disease is associated with mutations that disrupt function of a voltage-gated chloride channel, CLC-5, expressed in subapical endosomes of the proximal tubule and in other nephron segments. Impaired function of this channel disturbs reabsorption of filtered proteins, as well as other transport functions of the proximal tubule, and leads, apparently indirectly, to hypercalciuria and renal failure. FHHNC results from mutations in paracellin-1, a tight-junction protein that appears to be important in conducting or regulating paracellular cation transport. Impaired function of paracellin-1 leads specifically to urinary losses of magnesium and calcium, but because transcellular transport is intact these patients do not have hypokalemia or salt wasting. Identification of both genes represent triumphs of a genetic approach to solving problems of pathophysiology.
Collapse
Affiliation(s)
- Stephen J Knohl
- Department of Medicine, State University of New York Upstate Medical University, Syracruse, NY 13210, USA
| | | |
Collapse
|
162
|
Bojarski C, Weiske J, Schöneberg T, Schröder W, Mankertz J, Schulzke JD, Florian P, Fromm M, Tauber R, Huber O. The specific fates of tight junction proteins in apoptotic epithelial cells. J Cell Sci 2004; 117:2097-107. [PMID: 15054114 DOI: 10.1242/jcs.01071] [Citation(s) in RCA: 134] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
The polarized morphology of epithelial cells depends on the establishment and maintenance of characteristic intercellular junctions. The dramatic morphological changes observed in apoptotic epithelial cells were ascribed at least in part to the specific fragmentation of components of adherens junctions and desmosomes. Little, however, is known about tight junctions during apoptosis. We have found that after induction of apoptosis in epithelial cells, tight junction proteins undergo proteolytic cleavage in a distinctive manner correlated with a disruption of tight junctions. The transmembrane protein occludin and, likewise, the cytoplasmic adaptor proteins ZO-1 and ZO-2 are fragmented by caspase cleavage. In addition, occludin is cleaved at an extracellular site by a metalloproteinase. The caspase cleavage site in occludin was mapped C-terminally to Asp(320) within the C-terminal cytoplasmic domain. Mutagenesis of this site efficiently blocked fragmentation. In the presence of caspase and/or metalloproteinase inhibitors, fragmentation of occludin, ZO-1 and ZO-2 was blocked and cellular morphology was almost fully preserved. Interestingly, two members of the claudin family of transmembrane tight junction proteins exhibited a different behavior. While the amount of claudin-2 protein was reduced similarly to occludin, ZO-1 and ZO-2, claudin-1 was either fully preserved or was even increased in apoptotic cells.
Collapse
Affiliation(s)
- Christian Bojarski
- Institute of Clinical Chemistry and Pathobiochemistry, Charité - Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
163
|
Schlingmann KP, Konrad M, Seyberth HW. Genetics of hereditary disorders of magnesium homeostasis. Pediatr Nephrol 2004; 19:13-25. [PMID: 14634861 DOI: 10.1007/s00467-003-1293-z] [Citation(s) in RCA: 56] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2003] [Revised: 07/25/2003] [Accepted: 07/28/2003] [Indexed: 10/26/2022]
Abstract
Magnesium plays an essential role in many biochemical and physiological processes. Homeostasis of magnesium is tightly regulated and depends on the balance between intestinal absorption and renal excretion. During the last decades, various hereditary disorders of magnesium handling have been clinically characterized and genetic studies in affected individuals have led to the identification of some molecular components of cellular magnesium transport. In addition to these hereditary forms of magnesium deficiency, recent studies have revealed a high prevalence of latent hypomagnesemia in the general population. This finding is of special interest in view of the association between hypomagnesemia and common chronic diseases such as diabetes, coronary heart disease, hypertension, and asthma. However, valuable methods for the diagnosis of body and tissue magnesium deficiency are still lacking. This review focuses on clinical and genetic aspects of hereditary disorders of magnesium homeostasis. We will review primary defects of epithelial magnesium transport, disorders associated with defects in Ca(2+)/ Mg(2+) sensing, as well as diseases characterized by renal salt wasting and hypokalemic alkalosis, with special emphasis on disturbed magnesium homeostasis.
Collapse
Affiliation(s)
- Karl P Schlingmann
- Department of Pediatrics, Philipps University, Deutschhausstrasse 12, 35037 Marburg, Germany
| | | | | |
Collapse
|
164
|
Tajima T, Nakae J, Fujieda K. Two heterozygous mutations of CLDN16 in a Japanese patient with FHHNC. Pediatr Nephrol 2003; 18:1280-2. [PMID: 14586675 DOI: 10.1007/s00467-003-1304-0] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2003] [Revised: 07/23/2003] [Accepted: 07/25/2003] [Indexed: 10/26/2022]
Abstract
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC, MIN 248250) is a rare autosomal recessive tubular disorder that eventually progresses to renal failure. However, the progression to end-stage renal failure can vary from patient to patient. A primary defect is related to impaired tubular resorption of magnesium and calcium in the thick ascending limb of Henle's loop. Recently, paracellin-1 was identified as a renal tight junction protein predominantly expressed in TAL. Mutations of its gene (CLDN16) have been shown to cause FHHNC. We describe a sporadic Japanese case of FHHNC. The male patient showed hematuria, hypercalciuria, and nephrocalcinosis at 5 years of age. Hypomagnesemia was also noticed at this time. As renal function gradually deteriorated, further evaluation was performed at 14 years of age and a diagnosis of FHHNC was made. Despite several medications (magnesium supplementation, citrate, and hydrochlorothiazide), he eventually progressed to renal insufficiency at 19 years of age. Analysis of the CLDN16 gene demonstrated two heterozygous mutations (R149Q and R216C). Mutations of the same amino acids have already been described in FHHNC and thus these mutations might be the cause of the disease in our patient. Hence, we confirm the genetic impairment of the CLDN16 gene in a Japanese patient with FHHNC.
Collapse
Affiliation(s)
- Toshihiro Tajima
- Department of Pediatrics, Hokkaido University School of Medicine, N15, W7, Sapporo 060-0835, Japan
| | | | | |
Collapse
|
165
|
Müller D, Kausalya PJ, Claverie-Martin F, Meij IC, Eggert P, Garcia-Nieto V, Hunziker W. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am J Hum Genet 2003; 73:1293-301. [PMID: 14628289 PMCID: PMC1180395 DOI: 10.1086/380418] [Citation(s) in RCA: 127] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2003] [Accepted: 09/15/2003] [Indexed: 11/03/2022] Open
Abstract
Mutations in the gene coding for the renal tight junction protein claudin 16 cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis, an autosomal recessive disorder of renal Ca(2+) and Mg(2+) handling that progressively leads to chronic renal failure, with nephrolithiasis having been reported in heterozygous carriers. Screening a cohort of 11 families with idiopathic hypercalciuria identified a novel homozygous mutation in the claudin 16 gene in two families. In contrast to classical symptoms of familial hypomagnesemia with hypercalciuria and nephrocalcinosis, the patients displayed serious but self-limiting childhood hypercalciuria with preserved glomerular filtration rate. The mutation results in inactivation of a PDZ-domain binding motif, thereby disabling the association of the tight junction scaffolding protein ZO-1 with claudin 16. In contrast to wild-type claudin 16, the mutant no longer localizes to tight junctions in kidney epithelial cells but instead accumulates in lysosomes. Thus, mutations at different intragenic sites in the claudin 16 gene may lead to particular clinical phenotypes with a distinct prognosis. Mutations in claudin 16 that affect interaction with ZO-1 lead to lysosomal mistargeting, providing-for the first time, to our knowledge-insight into the molecular mechanism of a disease-associated mutation in the claudin 16 gene.
Collapse
Affiliation(s)
- Dominik Müller
- Charité Children’s Hospital, Department of Pediatric Nephrology, Berlin; Epithelial Cell Biology Laboratory, Institute of Molecular and Cell Biology, Singapore; Research and Pediatric Nephrology Units, Nuestra Senora de Candelaria University Hospital, Santa Cruz de Tenerife, Tenerife, Spain; Department of Pharmacology/Toxicology, Nijmegen Center for Molecular Life Sciences, Nijmegen, The Netherlands; and University Children’s Hospital Kiel, Kiel, Germany
| | - P. Jaya Kausalya
- Charité Children’s Hospital, Department of Pediatric Nephrology, Berlin; Epithelial Cell Biology Laboratory, Institute of Molecular and Cell Biology, Singapore; Research and Pediatric Nephrology Units, Nuestra Senora de Candelaria University Hospital, Santa Cruz de Tenerife, Tenerife, Spain; Department of Pharmacology/Toxicology, Nijmegen Center for Molecular Life Sciences, Nijmegen, The Netherlands; and University Children’s Hospital Kiel, Kiel, Germany
| | - Felix Claverie-Martin
- Charité Children’s Hospital, Department of Pediatric Nephrology, Berlin; Epithelial Cell Biology Laboratory, Institute of Molecular and Cell Biology, Singapore; Research and Pediatric Nephrology Units, Nuestra Senora de Candelaria University Hospital, Santa Cruz de Tenerife, Tenerife, Spain; Department of Pharmacology/Toxicology, Nijmegen Center for Molecular Life Sciences, Nijmegen, The Netherlands; and University Children’s Hospital Kiel, Kiel, Germany
| | - Iwan C. Meij
- Charité Children’s Hospital, Department of Pediatric Nephrology, Berlin; Epithelial Cell Biology Laboratory, Institute of Molecular and Cell Biology, Singapore; Research and Pediatric Nephrology Units, Nuestra Senora de Candelaria University Hospital, Santa Cruz de Tenerife, Tenerife, Spain; Department of Pharmacology/Toxicology, Nijmegen Center for Molecular Life Sciences, Nijmegen, The Netherlands; and University Children’s Hospital Kiel, Kiel, Germany
| | - Paul Eggert
- Charité Children’s Hospital, Department of Pediatric Nephrology, Berlin; Epithelial Cell Biology Laboratory, Institute of Molecular and Cell Biology, Singapore; Research and Pediatric Nephrology Units, Nuestra Senora de Candelaria University Hospital, Santa Cruz de Tenerife, Tenerife, Spain; Department of Pharmacology/Toxicology, Nijmegen Center for Molecular Life Sciences, Nijmegen, The Netherlands; and University Children’s Hospital Kiel, Kiel, Germany
| | - Victor Garcia-Nieto
- Charité Children’s Hospital, Department of Pediatric Nephrology, Berlin; Epithelial Cell Biology Laboratory, Institute of Molecular and Cell Biology, Singapore; Research and Pediatric Nephrology Units, Nuestra Senora de Candelaria University Hospital, Santa Cruz de Tenerife, Tenerife, Spain; Department of Pharmacology/Toxicology, Nijmegen Center for Molecular Life Sciences, Nijmegen, The Netherlands; and University Children’s Hospital Kiel, Kiel, Germany
| | - Walter Hunziker
- Charité Children’s Hospital, Department of Pediatric Nephrology, Berlin; Epithelial Cell Biology Laboratory, Institute of Molecular and Cell Biology, Singapore; Research and Pediatric Nephrology Units, Nuestra Senora de Candelaria University Hospital, Santa Cruz de Tenerife, Tenerife, Spain; Department of Pharmacology/Toxicology, Nijmegen Center for Molecular Life Sciences, Nijmegen, The Netherlands; and University Children’s Hospital Kiel, Kiel, Germany
| |
Collapse
|
166
|
Enríquez R, Sirvent AE, Amorós F, Martínez M, Cabezuelo JB, Reyes A. Renal hypomagnesemia, hypercalciuria and nephrocalcinosis in a middle-aged man. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY 2003; 37:93-5. [PMID: 12745755 DOI: 10.1080/00365590310008802] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
We report a 41-year-old man with hypomagnesemia, hypercalciuria, nephrocalcinosis, myopia and horizontal nystagmus. The hypomagnesemia was due to primary renal magnesium loss. He was diagnosed as having the syndrome of renal hypomagnesemia, hypercalciuria and nephrocalcinosis. This is a rare condition generally diagnosed by the first to third decades of life. Renal failure is common and end-stage renal disease can occur in children or young adults. The patient was treated with oral magnesium, chlorthalidone, potassium citrate and allopurinol and was followed up for 3 years. Treatment resulted in an improvement in hypercalciuria but serum magnesium level could not be normalized. The patient's renal function remains stable, with a mild degree of renal insufficiency.
Collapse
Affiliation(s)
- R Enríquez
- Nephrology Section, General Hospital of Elche, Elche, Alicante, Spain
| | | | | | | | | | | |
Collapse
|
167
|
Konrad M, Weber S. Recent advances in molecular genetics of hereditary magnesium-losing disorders. J Am Soc Nephrol 2003; 14:249-60. [PMID: 12506158 DOI: 10.1097/01.asn.0000049161.60740.ce] [Citation(s) in RCA: 78] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Recent advances in molecular genetics in hereditary hypomagnesemia substantiated the role of a variety of genes and their encoded proteins in human magnesium transport mechanisms. This knowledge on underlying genetic defects helps to distinguish different clinical subtypes and gives first insight into molecular components involved in magnesium transport. By mutation analysis and functional protein studies, novel pathophysiologic aspects were elucidated. For some of these disorders, transgenic animal models were generated to study genotype-phenotype relations and disease pathology. This review will discuss genetic and clinical aspects of familial disorders associated with magnesium wasting and focuses on the recent progress that has been made in molecular genetics. Besides isolated renal forms of hereditary hypomagnesemia, the following disorders will also be presented: familial hypomagnesemia with hypercalciuria and nephrocalcinosis, hypomagnesemia with secondary hypocalcemia, Ca2+/Mg2+-sensing receptor-associated disorders, and disorders associated with renal salt-wasting and hypokalemic metabolic alkalosis, comprising the Gitelman syndrome and the Bartter-like syndromes.
Collapse
|
168
|
Abstract
For homeostasis in multicellular organisms, isolation and compartmentalisation of the internal environment are essential, and are established by various cellular sheets. For these cellular sheets to function as barriers, the intercellular route must be sealed. Recent advances reveal that claudins - major cell adhesion molecules in tight junctions - are directly involved in this intercellular sealing, not only in simple but also in stratified cellular sheets in vertebrates.
Collapse
Affiliation(s)
- Shoichiro Tsukita
- Department of Cell Biology, Kyoto University Faculty of Medicine, Yoshida-Konoe, Sakyo-ku, Kyoto, Japan.
| | | |
Collapse
|
169
|
Abstract
The serum levels of parathyroid hormone and magnesium depend on each other in a complex manner. The secretion of parathyroid hormone by the parathyroid is physiologically controlled by the serum calcium level, but magnesium can exert similar effects. While low levels of magnesium stimulate parathyroid hormone secretion, very low serum concentrations induce a paradoxical block. This block leads to clinically relevant hypocalcemia in severely hypomagnesiemic patients. The mechanism of this effect has recently been traced to an activation of the alpha-subunits of heterotrimeric G-proteins. This activation mimicks activation of the calcium sensing receptor and thus causes inhibition of parathyroid hormone secretion. In addition to the effects of magnesium on parathyroid hormone secretion, parathyroid hormone in turn regulates magnesium homeostasis by modulating renal magnesium reabsorption. The distal convoluted tubule is of crucial importance for parathyroid hormone-regulated magnesium homeostasis.
Collapse
Affiliation(s)
- Thorsten Vetter
- Institute for Pharmacology and Toxicology, Würzburg, Germany
| | | |
Collapse
|
170
|
Weber S, Schlingmann KP, Peters M, Nejsum LN, Nielsen S, Engel H, Grzeschik KH, Seyberth HW, Gröne HJ, Nüsing R, Konrad M. Primary gene structure and expression studies of rodent paracellin-1. J Am Soc Nephrol 2001; 12:2664-2672. [PMID: 11729235 DOI: 10.1681/asn.v12122664] [Citation(s) in RCA: 43] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
The novel member of the claudin multigene family, paracellin-1/claudin-16, encoded by the gene PCLN1, is a renal tight junction protein that is involved in the paracellular transport of magnesium and calcium in the thick ascending limb of Henle's loop. Mutations in human PCLN1 are associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis, an autosomal recessive disease that is characterized by severe renal magnesium and calcium loss. The complete coding sequences of mouse and rat Pcln1 and the murine genomic structure are here presented. Full-length cDNAs are 939 and 1514 bp in length in mouse and rat, respectively, encoding a putative open-reading frame of 235 amino acids in both species with 99% identity. Exon-intron analysis of the human and mouse genes revealed a 100% homology of coding exon lengths and splice-site loci. By radiation hybrid mapping, the murine Pcln1 gene was assigned directly to marker D16Mit133 on mouse chromosome 16 (syntenic to a locus on human chromosome 3q27, which harbors the human PCLN1 gene). Mouse multiple-tissue Northern blot showed Pcln1 expression exclusively in the kidney. The expression profile along the nephron was analyzed by reverse transcriptase-PCR on microdissected nephron segments and immunohistochemistry of rat kidney. Paracellin-1 expression was restricted to distal tubular segments including the thick ascending limb of Henle's loop, the distal tubule, and the collecting duct. The identification and characterization of the rodent Pcln1 genes provide the basis for further studies of paracellin-1 function in suitable animal models.
Collapse
Affiliation(s)
- Stefanie Weber
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Karl P Schlingmann
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Melanie Peters
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Lene Niemann Nejsum
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Søren Nielsen
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Hartmut Engel
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Karl-Heinz Grzeschik
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Hannsjörg W Seyberth
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Hermann-Joseph Gröne
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Rolf Nüsing
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| | - Martin Konrad
- *Department of Pediatrics, Philipps University, Marburg, Germany; Department of Cell Biology, Institute of Anatomy, University of Aarhus, Aarhus, Denmark; Institute of Human Genetics, Philipps University, Marburg, Germany; Deutsches Krebsforschungszentrum, Heidelberg, Germany
| |
Collapse
|